Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Program
        • PEP++ project
        • PEP4LEP 2.0 & PEP4LEP
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [16]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
      • Health-related Perception Inquiry
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • Prevention of Leprosy (SDR-PEP) Toolkit
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

PERFIL CLÍNICO E EPIDEMIOLÓGICO DOS PACIENTES PORTADORES DE HANSENÍASE DA UNIDADE DE REFERÊNCIA ESPECIALIZADA EM DERMATOLOGIA SANITÁRIA DR MARCELO CÂNDIA

Revista CPAQV. Centro de Pesquisas Avançadas em Qualidade de Vida. 2020;
Download PDF
Publication

Distribuição espacial da hanseníase em menores de 15 anos de idade, no município de Belém, estado do Pará, Brasil

Fujishima MA, Lemos LXDO, Matos HJD. Instituto Evandro Chagas. Revista Pan-Amazônica de Saúde. 2020;
Download PDF
Publication

Pensar siempre en lepra

Maya YC, Torres AG, Díaz YG. Folia Dermatológica Cubana. 2018;
Download PDF
Publication

Leprosy: epidemiology of the morbidity, mortality and public spending in the northeast of brazil

Júnior EVDS, Cruz DP, Caricchio GMN, et al. Universidade Federal do Estado do Rio de Janeiro UNIRIO. Revista de Pesquisa Cuidado é Fundamental Online. 2020;
Download PDF
Publication

Nursing practice regarding care strategy towards clients affected by leprosy

Costa CRDL, Gonçalves de Brito KK, Santana EMFD, et al. Universidade Federal do Estado do Rio de Janeiro UNIRIO. Revista de Pesquisa Cuidado é Fundamental Online. 2020;
Download PDF
Publication

Effect of dialyzable leukocyte extract, sodium butyrate, and valproic acid in the development of anergy in murine leprosy.

Rojas-Espinosa O, Moreno-García S, Arce-Paredes P, et al. International journal of mycobacteriology. 2020; 9 (3) : 268-273.
Download PDF
Publication

From leprosy to COVID-19, how stigma makes it harder to fight epidemics

Chandrashekhar V. American Association for the Advancement of Science. 2020;
Download PDF
Publication

Mononeuritis Multiplex as Initial Manifestation of Pure Neuritic Leprosy-A Forgotten Cause: Clinical, Electrodiagnostic and Pathologic Correlations.

Shelley B, Chakraborti S, Manjunath M. Neurology India. 2020; 68 (4) : 922-926.
Download PDF
Publication

Lazarine leprosy: A unique phenomenon of leprosy.

Wankhade V, Shah V, Singh R, et al. International journal of mycobacteriology. 2020; 9 (3) : 329-331.
Download PDF
Publication

The clinical trend of leprosy from 2000-2016 in Kaohsiung, a major international harbor city in Taiwan, where leprosy is almost extinguished.

Huang H, Lee C, Lin S. Japanese journal of infectious diseases. 2020;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 369
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD